125 related articles for article (PubMed ID: 37951194)
1. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
Giri PS; Bharti AH; Kode J; Begum R; Dwivedi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
[TBL] [Abstract][Full Text] [Related]
2. Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
Giri PS; Bharti AH; Begum R; Dwivedi M
Immunology; 2022 Nov; 167(3):314-327. PubMed ID: 35754117
[TBL] [Abstract][Full Text] [Related]
3. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of nuclear factor of activated T cells' 3'UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population.
Giri P; Bhimani R; Patil S; Dwivedi M
Gene; 2023 Sep; 880():147629. PubMed ID: 37429370
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients.
Giri PS; Dwivedi M; Laddha NC; Begum R; Bharti AH
Pigment Cell Melanoma Res; 2020 Jul; 33(4):566-578. PubMed ID: 31917889
[TBL] [Abstract][Full Text] [Related]
6. Decreased
Giri PS; Bharti AH; Dwivedi M
J Immunol Res; 2022; 2022():3426717. PubMed ID: 36157881
[TBL] [Abstract][Full Text] [Related]
7. Compromised melanocyte survival due to decreased suppression of CD4
Shah F; Giri PS; Bharti AH; Dwivedi M
Exp Dermatol; 2024 Jan; 33(1):e14982. PubMed ID: 37994568
[TBL] [Abstract][Full Text] [Related]
8. Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo.
Giri PS; Patel SS; Dwivedi M
Hum Immunol; 2024 Jan; 85(1):110737. PubMed ID: 38057201
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
Giri PS; Mistry J; Dwivedi M
J Immunol Res; 2022; 2022():6952299. PubMed ID: 36164321
[TBL] [Abstract][Full Text] [Related]
10. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
Giri PS; Patel S; Begum R; Dwivedi M
Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
[TBL] [Abstract][Full Text] [Related]
11. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.
Lili Y; Yi W; Ji Y; Yue S; Weimin S; Ming L
PLoS One; 2012; 7(5):e37513. PubMed ID: 22649532
[TBL] [Abstract][Full Text] [Related]
12. Implication of regulatory T cells' telomere shortening in pathogenesis of generalized vitiligo.
Giri P; Thakor F; Dwivedi M
Hum Immunol; 2024 May; ():110812. PubMed ID: 38755031
[TBL] [Abstract][Full Text] [Related]
13. Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.
Dwivedi M; Laddha NC; Arora P; Marfatia YS; Begum R
Pigment Cell Melanoma Res; 2013 Jul; 26(4):586-91. PubMed ID: 23574980
[TBL] [Abstract][Full Text] [Related]
14. Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor.
Zeng YQ; Liu XS; Wu S; Zou C; Xie Q; Xu SM; Jin XW; Li W; Zhou A; Dai Z
Am J Transplant; 2015 Jul; 15(7):1782-92. PubMed ID: 25808405
[TBL] [Abstract][Full Text] [Related]
15. Kaempferol enhances the suppressive function of Treg cells by inhibiting FOXP3 phosphorylation.
Lin F; Luo X; Tsun A; Li Z; Li D; Li B
Int Immunopharmacol; 2015 Oct; 28(2):859-65. PubMed ID: 25870037
[TBL] [Abstract][Full Text] [Related]
16. Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity.
Li Q; Shakya A; Guo X; Zhang H; Tantin D; Jensen PE; Chen X
J Immunol; 2012 May; 188(9):4268-77. PubMed ID: 22490438
[TBL] [Abstract][Full Text] [Related]
17. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
[TBL] [Abstract][Full Text] [Related]
18. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y
Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
[TBL] [Abstract][Full Text] [Related]
20. T regulatory cells in cord blood--FOXP3 demethylation as reliable quantitative marker.
Liu J; Lluis A; Illi S; Layland L; Olek S; von Mutius E; Schaub B
PLoS One; 2010 Oct; 5(10):e13267. PubMed ID: 20967272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
